Trial · NCT02804399
Participant flow18
How many started, completed or left each group, period by period.
1 to 18 of 18
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Period 1 | STARTED | PF-06463922 100 mg Single Dose (SD) | 12 | |
| Period 1 | STARTED | Rifampin 600 Once a Day (QD) + PF-06463922 100 mg SD | 0 | |
| Period 1 | COMPLETED | PF-06463922 100 mg Single Dose (SD) | 12 | |
| Period 1 | COMPLETED | Rifampin 600 Once a Day (QD) + PF-06463922 100 mg SD | 0 | |
| Period 1 | NOT COMPLETED | PF-06463922 100 mg Single Dose (SD) | 0 | |
| Period 1 | NOT COMPLETED | Rifampin 600 Once a Day (QD) + PF-06463922 100 mg SD | 0 | |
| Washout Period at Least 10 Days | STARTED | PF-06463922 100 mg Single Dose (SD) | 12 | |
| Washout Period at Least 10 Days | STARTED | Rifampin 600 Once a Day (QD) + PF-06463922 100 mg SD | 0 | |
| Washout Period at Least 10 Days | COMPLETED | PF-06463922 100 mg Single Dose (SD) | 12 | |
| Washout Period at Least 10 Days | COMPLETED | Rifampin 600 Once a Day (QD) + PF-06463922 100 mg SD | 0 | |
| Washout Period at Least 10 Days | NOT COMPLETED | PF-06463922 100 mg Single Dose (SD) | 0 | |
| Washout Period at Least 10 Days | NOT COMPLETED | Rifampin 600 Once a Day (QD) + PF-06463922 100 mg SD | 0 | |
| Period 2 | STARTED | PF-06463922 100 mg Single Dose (SD) | 0 | |
| Period 2 | STARTED | Rifampin 600 Once a Day (QD) + PF-06463922 100 mg SD | 12 | |
| Period 2 | COMPLETED | PF-06463922 100 mg Single Dose (SD) | 0 | |
| Period 2 | COMPLETED | Rifampin 600 Once a Day (QD) + PF-06463922 100 mg SD | 11 | |
| Period 2 | NOT COMPLETED | PF-06463922 100 mg Single Dose (SD) | 0 | |
| Period 2 | NOT COMPLETED | Rifampin 600 Once a Day (QD) + PF-06463922 100 mg SD | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02804399/flow